Oral Concurrent Session 7 - Clinical Obstetrics & Postpartum
Oral Concurrent Sessions
We performed a randomized, prospective, controlled trial, at a single tertiary medical center, between June 2020 to June 2022. Vaginally delivered women were randomly assigned to one of two groups: group 1: oral analgesics of Paracetamol 1 g + Ibuprofen 400 mg every 6 h for the first 24 hours postpartum (per-protocol analgesia group); group 2: same oral analgesics according to maternal request (on-demand group). The primary outcome was pain level during the 1st 24 hours post-delivery, measured on a 10-point visual analog scale (VAS). We estimated that 100 women per group would provide 80% power to identify a 20% difference in the primary outcome.
Results:
From 2020-2022, 200 women were enrolled and included in the analysis: 100 (50%) in study group (per-protocol analgesia) and 100 (50%) in control group (on-demand analgesia). Baseline and delivery characteristics were comparable for all relevant variables, including oxytocin augmentation, epidural anesthesia, episiotomy rate and neonatal weight. VAS score was comparable between study groups (5.31+1.92 vs. 5.29+1.67, p=0.626), even following sub-analysis for nulliparity, episiotomy, and vacuum assisted delivery. However, breastfeeding rates were higher in the per-protocol analgesia group (98% vs. 88%, p=0.006). Additionally, higher satisfaction rates were found among the per-protocol analgesia group (p< 0.05). Women in the per-protocol group received more analgesic treatment with no reported side effects.
Conclusion:
A fixed analgesic protocol for postpartum pain management, compared with an on-demand protocol, following vaginal delivery, is associated with higher breastfeeding rates and better maternal satisfaction though similar VAS scores.